Evaxion Biotech opens new office and laboratories to support future growth
COPENHAGEN: Evaxion Biotech A/S (Nasdaq: EVAX), a clinical-stage biotechnology company specializing in the development of AI-driven immunotherapies, announced the opening of its new corporate headquarters and research laboratory facility located…